Tech Company Financing Transactions
Vensun Pharmaceuticals Funding Round
JW Asset Management joined a $15.8 million Series B capital raise for Vensun Pharmaceuticals. The round was announced on 12/20/2013.
Transaction Overview
Company Name
Announced On
12/20/2013
Transaction Type
Venture Equity
Amount
$15,800,000
Round
Series B
Investors
JW Asset Management (Lead Investor) (Jason Wild)
Proceeds Purpose
This financing will provide us with the ability to increase the number of products under development and explore additional in-license opportunities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
790 Township Line Rd. 250
Yardley, PA 19067
USA
Yardley, PA 19067
USA
Phone
Website
Email Address
Overview
Vensun Pharmaceuticals, Inc., based in Yardley, Pennsylvania, was established in July 2011 and is a rapidly emerging pharmaceutical company developing a unique portfolio of generic prescription products in various dosage forms covering a broad range of therapeutic categories.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Hem Pandya
Chief Scientific Officer
Kamlesh Haribhakti
VP - Bus. Development
Rajeev Mohan
VP - Finance
Nitin Kotak
VP - Operations
George Sager
VP - Sales
Josh Gordon
Browse more venture capital transactions:
Prev: 12/20/2013: SynDevRx venture capital transaction
Next: 12/20/2013: Respira Therapeutics venture capital transaction
Share this article
About Database of VC Transactions
We document every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs